These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3305118)

  • 41. Refractory duodenal ulcer healing and relapse: comparison of omeprazole with Helicobacter pylori eradication.
    Avsar E; Kalayci C; Tözün N; Lawrence R; Kiziltas S; Gültekin O; Ulusoy NB
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):449-52. PubMed ID: 8804873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of duodenal ulcer recurrence. A new prospect].
    Soulé JC
    Presse Med; 1991 Mar; 20(10):465-70. PubMed ID: 1673786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevention of recurrence with bismuth subsalicylate in a patient with recurrent and H2 receptor antagonist refractory duodenal ulcer].
    Bayerdörffer E; Mannes GA; Pfaller P; Sauerbruch T
    Internist (Berl); 1989 Jun; 30(6):390-2. PubMed ID: 2668217
    [No Abstract]   [Full Text] [Related]  

  • 45. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs].
    Mach T
    Folia Med Cracov; 1995; 36(1-4):53-75. PubMed ID: 8834668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL).
    Wieriks J; Hespe W; Jaitly KD; Koekkoek PH; Lavy U
    Scand J Gastroenterol Suppl; 1982; 80():11-6. PubMed ID: 6962539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peptic ulcer and Helicobacter pylori. Comments on the authors' cases].
    Dallera F; Gendarini A; Scanzi G
    Recenti Prog Med; 1993 Jan; 84(1):34-7. PubMed ID: 8430247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled trial comparing De-Nol tablets with De-Nol liquid in treatment of duodenal ulcer.
    Hamilton I; Axon AT
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):362. PubMed ID: 6780025
    [No Abstract]   [Full Text] [Related]  

  • 51. Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)).
    Li W; Jin L; Zhu N; Hou X; Deng F; Sun H
    J Am Chem Soc; 2003 Oct; 125(41):12408-9. PubMed ID: 14531674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR; Klass HJ; Jones PE
    Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [De-Nol in the treatment of patients with duodenal peptic ulcer].
    Starodub IeM; Havryliuk MIe
    Lik Sprava; 1993 Jan; (1):91-3. PubMed ID: 8379149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colloidal bismuth subcitrate and ranitidine in the short-term treatment of benign gastric ulcer. An endoscopically controlled trial.
    Parente F; Lazzaroni M; Petrillo M; Bianchi Porro G
    Scand J Gastroenterol Suppl; 1986; 122():42-5. PubMed ID: 3465027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Misoprostol and de-nol in the treatment of patients with cimetidine-resistant stomach ulcer].
    Stasiewicz J; Raimer M; Kozuszyńska M; Szałaj W; Slezak L
    Pol Arch Med Wewn; 1989 Jan; 81(1):21-9. PubMed ID: 2515527
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of colloidal bismuth (De-Nol) in the treatment of duodenal ulcer employing endoscopic selection and follow up.
    Salmon PR; Brown P; Williams R; Read AE
    Gut; 1974 Mar; 15(3):189-93. PubMed ID: 4601523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis.
    Marshall BJ; Armstrong JA; Francis GJ; Nokes NT; Wee SH
    Digestion; 1987; 37 Suppl 2():16-30. PubMed ID: 3622946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid.
    Lee SP
    Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of colloidal bismuth subcitrate and aluminum hydroxide on gastric and duodenal levels of prostaglandin E2].
    Estela R; Feller A; Backhouse C; Castro R; Ugarte G
    Rev Med Chil; 1984 Oct; 112(10):975-81. PubMed ID: 6399150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.